Stem cells [electronic resource] : therapeutic innovations under control / Nicole Arrighi.
- 作者： Arrighi, Nicole, author.
- 其他題名：
- Innovation, benefits and risk in biotechnology set.
- 出版： London, UK :Kidlington, Oxford, UK : ISTE Press ;Elsevier 2018.
- 叢書名： Innovation, benefits and risk in biotechnology set
- 主題： Stem cells--Therapeutic use. , Stem Cells. , HEALTH & FITNESS--Diseases--General. , MEDICAL--Clinical Medicine. , MEDICAL--Diseases. , MEDICAL--Evidence-Based Medicine. , MEDICAL--Internal Medicine. , Electronic books. , Electronic books.
- ISBN： 9780081025888 (electronic bk.) 、 0081025882 (electronic bk.) 、 9781785482540 (print) 、 1785482548
- URL：
點擊此處查看電子書
點擊此處查看電子書
- 一般註：Includes bibliographical references and index. Front Cover; Stem Cells: Therapeutic Innovations Under Control; Copyright; Contents; Acknowledgments; Introduction; Chapter 1. Definition and Classification of Stem Cells; 1.1. Two characteristics specific to stem cells; 1.2. Adult stem cells or specific stem cells of a tissue; 1.3. Embryonic stem cells; 1.4. Induced pluripotent stem cells; Chapter 2. Stem Cells as a Necessary Experimental Platform in Medical Research; 2.1. A tool for modeling human pathologies; 2.2. A pharmaceutical screening tool; 2.3. A predictive toxicology tool in the pharmaceutical industry. Chapter 3. Stem Cells at the Core of Cell Therapy3.1. Blood stem cells, pioneers of cell therapy; 3.2. Skin stem cells; 3.3. Stem cells at the core of clinical research; Chapter 4. Stem Cells for Regenerative Medicine in Humans; 4.1. Biomaterials in tissue engineering; 4.2. Nanofibers associated with stem cells organized in 3D; 4.3. 3D printing from stem cells; 4.4. Today's regenerative medicine; Chapter 5. Bioethics: Regulatory Framework for Human Stem Cells; 5.1. The legal position relating to stem cell research; 5.2. The patentability of stem cell research. 5.3. Cell- and tissue-based therapy productsGlossary; Bibliography; Index; Back Cover. 110年度臺灣學術電子書暨資料庫聯盟採購
-
讀者標籤：
- 系統號： 000291830 | 機讀編目格式
館藏資訊
Stem Cells: Therapeutic Innovations under Control traces the discovery of stem cells and induced pluripotent cells. It establishes the link between knowledge about cell development and tissue engineering, and presents perspectives in regenerative medicine. Cell proliferation and tissue architecture open up unexpected applications in tissue engineering, with the development of tissues or organs. In this context emerges the need to address the issue of bioethics and regulatory considerations. Because stem cells can multiply and differentiate into cells specific to a particular tissue or organ, they represent vast potential in the health field. Traces the discovery of stem cells to link knowledge of cell development with tissue engineering Presents prospects in regenerative medicine Establishes the link between knowledge about cell development and tissue engineering